Advancing Regulatory Science for Public Health

The IMEDS program is offered by the Reagan-Udall Foundation for the FDA through the FDA Amendments Act of 2007. IMEDS serves to advance the science and tools necessary to support post-market evidence generation on regulated products and to facilitate utilization of a robust secondary electronic healthcare data platform for generating better evidence on regulated products in the post-market settings.

Request for Public Comment: Draft 2015 IMEDS Methods Research Agenda

We are also in the annual process of updating the IMEDS-Methods Research Agenda to reflect the progress that we have made, and to ensure that the projects undertaken over the next twelve months reflect the goals and priorities of the stakeholders. A key priority in this process is receiving feedback from the community and from the public. Comments are due January 9th, 2015.
For more information, please review the full announcement here.

Be a Part of the IMEDS Research Lab

Do you want to know about research that is being completed in the lab? Find out about the IMEDS Research Laboratory, how to gain access, and the available datasets and tools to complete your research. Review the IMEDS Research Lab information.

IMEDS-Methods Research Agenda

For the IMEDS-Methods Research Agenda, please click here. If you have questions or comments reach us at:

Symposium on Health Care Data Analytics - Sept 28-30, 2014

Join biostatisticians and other scientists Sept. 28-30, 2014, in Seattle, Washington for the the 1st Seattle Symposium on Health Care Data Analytics featuring research on pragmatic clinical trial design, inference and prediction using EHR data, and drug and vaccine safety surveillance. Susan Gruber will be addressing "Gaps and opportunities: Methodologic challenges in post-market safety surveillance." View conference agenda (PDF).